Distinct regions of human eIF3 are sufficient for binding to the HCV IRES and the 40S ribosomal subunit.
Translation of the hepatitis C virus (HCV) genomic RNA initiates from an internal ribosome entry site (IRES) in its 5' untranslated region and requires a minimal subset of translation initiation factors to occur, namely eukaryotic initiation factor (eIF) 2 and eIF3. Low-resolution structural information has revealed how the HCV IRES RNA binds human eIF3 and the 40S ribosomal subunit and positions the start codon for initiation. However, the exact nature of the interactions between the HCV IRES RNA and the translational machinery remains unknown. Using limited proteolysis and mass spectrometry, we show that distinct regions of human eIF3 are sufficient for binding to the HCV IRES RNA and the 40S subunit. Notably, the eIF3 subunit eIF3b is protected by HCV IRES RNA binding, yet is exposed in the complex when compared to subunits eIF3e, eIF3f, eIF3h, and eIF3l. Limited proteolysis reveals that eIF3 binding to the 40S ribosomal subunit occurs through many redundant interactions that can compensate for each other. These data suggest how the HCV IRES binds to specific regions of eIF3 to target the translational machinery to the viral genomic RNA and provide a framework for modeling the architecture of intact human eIF3.
Cai
Qi
Q
California Institute for Quantitative Biosciences, University of California, Berkeley, CA 94720, USA.
Todorovic
Aleksandar
A
Andaya
Armann
A
Gao
Jingyun
J
Leary
Julie A
JA
Cate
Jamie H D
JH
D001483:Base Sequence; D001665:Binding Sites; D039621:Eukaryotic Initiation Factor-3 / Q000378:metabolism*; D016174:Hepacivirus / Q000502:physiology*; D006801:Humans; D013058:Mass Spectrometry; D008954:Models, Biological; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009690:Nucleic Acid Conformation; D011485:Protein Binding; D014176:Protein Biosynthesis; D012367:RNA, Viral / Q000378:metabolism*; D054682:Ribosome Subunits, Small, Eukaryotic / Q000378:metabolism*
D039621:Eukaryotic Initiation Factor-3; D012367:RNA, Viral
Nat Struct Mol Biol. 2009 Apr;16(4):397-404
19287397
EMBO J. 1997 Nov 17;16(22):6812-22
9362495
FEBS Lett. 2010 Jan 21;584(2):405-12
19896944
Mol Cell. 2007 Jun 22;26(6):811-9
17588516
Nucleic Acids Res. 1998 Jul 1;26(13):3179-87
9628916
Genes Dev. 2003 Mar 15;17(6):786-99
12651896
Nat Struct Biol. 2002 May;9(5):375-80
11927954
Mol Cell Proteomics. 2007 Jul;6(7):1135-46
17322308
J Am Soc Mass Spectrom. 2009 Sep;20(9):1699-706
19564121
RNA. 2001 Feb;7(2):194-206
11233977
Cell. 2004 Aug 20;118(4):465-75
15315759
J Biol Chem. 2004 Mar 5;279(10):8946-56
14688252
J Biol Chem. 1998 Jul 17;273(29):18573-85
9660829
Mol Cell Biol. 2004 Nov;24(21):9437-55
15485912
Cell. 2004 Oct 29;119(3):369-80
15507208
FEBS Lett. 2009 Jan 5;583(1):70-4
19059401
Nat Struct Biol. 2002 May;9(5):370-4
11927953
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18139-44
18599441
Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):16990-5
15563596
EMBO J. 2001 Jun 1;20(11):2954-65
11387228
RNA. 2010 Aug;16(8):1559-69
20584896
Trends Biochem Sci. 2006 Oct;31(10):553-62
16920360
J Virol. 1998 Jun;72(6):4775-82
9573242
Nat Protoc. 2006;1(6):2856-60
17406544
Liver Int. 2009 Jan;29 Suppl 1:74-81
19207969
Nat Rev Microbiol. 2007 Jan;5(1):29-38
17128284
EMBO J. 2007 Jul 25;26(14):3373-83
17581632
Science. 2005 Dec 2;310(5753):1513-5
16322461
J Mol Biol. 2004 Oct 29;343(4):805-17
15476802
J Biol Chem. 1999 Mar 26;274(13):8546-53
10085088